-
Short Interest Swings in Biotech Stocks (ALXN, AMGN, CELG)
Thursday, February 28, 2013 - 4:13pm | 841Read More...The short interest in biotech and emerging pharmaceutical companies was mixed again in the first two weeks of February. The number of shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA), Illumina (NASDAQ: ILMN) and Vertex Pharmaceuticals (NASDAQ: VRTX) grew somewhat between the January 31...
-
Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)
Tuesday, February 12, 2013 - 2:29pm | 829Read More...The short interest in biotech and emerging pharmaceutical companies was mixed again in the latter two weeks of January. The number of shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA), Dendreon (NASDAQ: DNDN), Gilead Sciences (NASDAQ: GILD), Vertex Pharmaceuticals (NASDAQ: VRTX) and VIVUS...
-
PetSmart and Other Secular Growth Picks (ACT, MYGN, PETM, HLF)
Monday, February 11, 2013 - 1:38pm | 770Read More...Slow economic growth like the United States is experiencing now is ideal for secular growth stocks. Bank of America defines secular growth in part as companies with earnings that have lower than average variability, as well as a forecast for between 10 percent and 20 percent earnings growth over...
-
Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)
Monday, November 12, 2012 - 2:24pm | 844Read More...The short interest in biotech and emerging pharmaceutical companies was mixed in the final two weeks of October. Shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA), Dendreon (NASDAQ: DNDN), Gilead Sciences (NASDAQ: GILD), Illumina (NASDAQ: ILMN) and VIVUS (NASDAQ: VVUS) grew somewhat between...
-
Dendreon, Pharmacyclics and Other Biotech Takeover Targets
Tuesday, July 10, 2012 - 2:07pm | 806Read More...M&A in the biotech and pharmaceutical industries continues. Bristol-Myers Squibb (NYSE: BMY) just announced it has agreed to acquire Amylin Pharmaceuticals (NASDAQ: AMLN) for $5.3 billion. And Human Genome Sciences (NASDAQ: HGSI) has opened itself up to bidders, including GlaxoSmithKline (NYSE...
-
Watson Pharmaceuticals Earnings Preview
Monday, July 25, 2011 - 11:13am | 647Read More...Watson Pharmaceuticals (NYSE: WPI) is scheduled to report its second-quarter 2011 results Tuesday, July 26, before the markets open. Strong first-quarter results pushed the share price to a new all-time high; can second-quarter results do the same? Analysts are looking for the drug maker to report...
-
Fifteen Health Care ETFs Trading Near 52-Week Highs
Thursday, July 21, 2011 - 1:57pm | 1271Read More...iShares Dow Jones US Healthcare Provider (NYSE: IHF) is up more than 19% year to date. The fund invests at least 90% of its assets in securities of the underlying index, which measures the performance of the health care providers sector of the U.S. equity market. Top holdings include UnitedHealth...
-
Twelve Health Care ETFs Trading Near 52-Week Highs
Wednesday, July 13, 2011 - 7:38am | 987Read More...PowerShares S&P SmallCap Health Care (NYSE: PSCH) is up nearly 22% year to date. The investment seeks to replicate the S&P SmallCap 600 Capped Health Care index, which is comprised of common stocks of U.S. health care companies. Top holdings include Regeneron Pharmaceuticals (NASDAQ: REGN...
-
Morgan Stanley Initiates Teva Pharmaceutical Coverage With An Equal-Weight Rating
Friday, November 12, 2010 - 10:11am | 68Read More...Morgan Stanley is initiating coverage on shares of Teva Pharmaceutical Industries (NASDAQ: TEVA) with an Equal-weight rating. “Teva is the world's leading generic pharma company, sells the largest multiple sclerosis drug (Copaxone), and is diversifying into a broader range of branded drug,” Morgan...
